Počet záznamov: 1  

Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer

  1. SYS0061350
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20150603152839.9
    100
      
    $a 20110412a2011 m y0sloy0103 ba
    101
    0-
    $a eng $d eng
    102
      
    $a SK
    200
    1-
    $a Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer $f E. Vrdoljak ... [et al.]
    215
      
    $c ilustr., grafy, tab.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl.
    463
    -1
    $1 001 sllk_un_cat*0060253 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 58, no. 2 (2011), s. 172-178 $1 210 $a Bratislava $c AEPress $d 2011 $1 215 $a 97-180
    541
    1-
    $a Kombinácia kapecitabínu a mitomycínu C ako prvolíniová liečba u pacientok s metastatickým karcinómom prsníka $z slo
    606
    1-
    $3 sllk_un_auth*d001943 $a nádory prsníka $x farmakoterapia $2 mesh
    606
    1-
    $3 sllk_un_auth*d009362 $a metastázy nádorové $2 mesh
    606
    1-
    $3 sllk_un_auth*d004359 $a farmakoterapia kombinovaná $x účinky nežiadúce $x využitie $2 mesh
    606
    2-
    $3 sllk_un_auth*d054697 $a cytostatiká $x aplikácia a dávkovanie $x použitie terapeutické $2 mesh
    606
    2-
    $3 sllk_un_auth*d016685 $a mitomycín $x použitie terapeutické $x toxicita $2 mesh
    606
    2-
    $3 sllk_un_auth*d018943 $a antracyklíny $2 mesh
    606
    2-
    $3 sllk_un_auth*d013534 $a prežívanie $2 mesh
    610
    2-
    $a karcinóm prsníka metastatický
    610
    2-
    $a kapecitabín
    610
    2-
    $a mitomycín C
    701
    -1
    $3 sllk_un_auth*p0059470 $a Vrdoljak $b Eduard $p Department of Oncology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070
    701
    -1
    $3 sllk_un_auth*0020224 $a Boban $b M. $p Department of Oncology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070
    701
    -1
    $3 sllk_un_auth*0020225 $a Omrcen $b T. $p Department of Oncology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070
    701
    -1
    $3 sllk_un_auth*0020226 $a Hrepic $b D. $p Department of Oncology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070
    701
    -1
    $3 sllk_un_auth*0020227 $a Fridl-Vidas $b V. $p Department of Radiology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070
    701
    -1
    $3 sllk_un_auth*0020228 $a Boskovic $b L. $p Department of Oncology, Clinical Hospital Split and University of Split school medicine, Split, Croatia $4 070
    801
    -0
    $a SK $b BA006 $c 20110412 $g AACR2
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.